Concurrent chemoradiotherapy with weekly docetaxel and cisplatin for locally advanced head and neck cancer: Phase I study

被引：0
|
作者：
Kim, H. S.
Park, K.
Ahn, M. J.
Park, Y.
Lee, S.
Baek, C.
Son, Y.
Jeong, H.
Ahn, Y.
Park, B.
机构：
[1] Samsung Med Ctr, Seoul, South Korea
[2] Hanyang Univ, Coll Med, Seoul 133791, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17026
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer
    Guntinas-Lichius, O
    Appenrodt, S
    Veelken, F
    Krug, B
    LARYNGOSCOPE, 2006, 116 (04): : 613 - 618
  • [22] WEEKLY GEMCITABINE AND CISPLATIN IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED HEAD-AND-NECK CANCER: PHASE I STUDY
    Viani, Gustavo Arruda
    Afonso, Sergio Luis
    Tavares, Vivian Cardoso
    Bernardes da Silva, Lucas Godoi
    Stefano, Eduardo Jose
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : E231 - E235
  • [23] CONCURRENT CHEMORADIATION WITH WEEKLY GEMCITABINE AND CISPLATIN IN LOCALLY ADVANCED CARCINOMA OF THE HEAD AND NECK
    Gaur, S.
    Kumar, S. S.
    Balasubramanian, P.
    ANNALS OF ONCOLOGY, 2014, 25
  • [24] Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma
    Takatsugu Mizumachi
    Akihiro Homma
    Tomohiko Kakizaki
    Tomohiro Sakashita
    Satoshi Kano
    Hiromitsu Hatakeyama
    Kazuhiko Tsuchiya
    Koichi Yasuda
    Rikiya Onimaru
    Hiroki Shirato
    Jun Taguchi
    Yasushi Shimizu
    Ichiro Kinoshita
    Hirotoshi Akita
    Satoshi Fukuda
    International Journal of Clinical Oncology, 2015, 20 : 431 - 437
  • [25] Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma
    Mizumachi, Takatsugu
    Homma, Akihiro
    Kakizaki, Tomohiko
    Sakashita, Tomohiro
    Kano, Satoshi
    Hatakeyama, Hiromitsu
    Tsuchiya, Kazuhiko
    Yasuda, Koichi
    Onimaru, Rikiya
    Shirato, Hiroki
    Taguchi, Jun
    Shimizu, Yasushi
    Kinoshita, Ichiro
    Akita, Hirotoshi
    Fukuda, Satoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 431 - 437
  • [26] Concurrent weekly docetaxel and hyperfractionated radiotherapy for advanced head and neck cancer
    Matsumoto, Fumihiko
    Karasawa, Kumiko
    Itoh, Shin
    Toda, Megumi
    Haruyama, Takuo
    Furukawa, Masayuki
    Ikeda, Katsuhisa
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3781 - 3786
  • [27] Treatment Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and Fluorouracil in Advanced Head and Neck Cancer
    Kusaka, Takahiro
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saito, Daisuke
    Oikawa, Shin-ichi
    Ikeda, Aya
    Tsuchida, Kodai
    Miyaguchi, Jun
    Ohashi, Yu
    Ariga, Hisanori
    Tanno, Kozo
    ANTICANCER RESEARCH, 2022, 42 (12) : 6047 - 6056
  • [28] Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer
    Janinis, J
    Papadakou, M
    Panagos, G
    Panousaki, A
    Georgoulias, V
    Hatzidaki, D
    Lefantzis, D
    Dokianakis, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 227 - 231
  • [29] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    H Katori
    M Tsukuda
    I Mochimatu
    J Ishitoya
    S Kawai
    Y Mikami
    H Matsuda
    Y Tanigaki
    C Horiuchi
    Y Ikeda
    T Taguchi
    M Ono
    T Yoshida
    S Hirose
    Y Sakuma
    K Yamamoto
    British Journal of Cancer, 2004, 90 : 348 - 352
  • [30] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, H
    Tsukuda, M
    Mochimatu, I
    Ishitoya, J
    Kawai, S
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Taguchi, T
    Ono, M
    Yoshida, T
    Hirose, S
    Sakuma, Y
    Yamamoto, K
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 348 - 352
12345